5 Stocks Pushing The Health Services Industry Lower

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 18 points (0.1%) at 15,482 as of Monday, July 15, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,893 issues advancing vs. 1,042 declining with 108 unchanged.

The Health Services industry currently sits up 0.7% versus the S&P 500, which is up 0.1%. On the negative front, top decliners within the industry include MiMedx Group ( MDXG), down 8.1%, and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.7%. Top gainers within the industry include WellCare Health Plans ( WCG), up 3.3%, Centene Corporation ( CNC), up 1.6%, Cooper Companies ( COO), up 1.4%, CareFusion ( CFN), up 1.1% and Laboratory Corporation of America Holdings ( LH), up 0.8%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Mindray Medical International ( MR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mindray Medical International is down $1.02 (-2.7%) to $36.85 on heavy volume. Thus far, 637,607 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 721,600 shares. The stock has ranged in price between $36.13-$37.29 after having opened the day at $36.40 as compared to the previous trading day's close of $37.87.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $4.5 billion and is part of the health care sector. Shares are up 17.2% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Mindray Medical International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Mindray Medical International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Edwards Life ( EW) is down $1.13 (-1.7%) to $66.72 on average volume. Thus far, 780,295 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $66.09-$67.89 after having opened the day at $67.71 as compared to the previous trading day's close of $67.85.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.4 billion and is part of the health care sector. Shares are down 27.0% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Edwards Life Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, DaVita HealthCare Partners ( DVA) is down $0.87 (-0.7%) to $120.36 on light volume. Thus far, 263,969 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 895,500 shares. The stock has ranged in price between $120.10-$122.03 after having opened the day at $121.66 as compared to the previous trading day's close of $121.23.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.7 billion and is part of the health care sector. Shares are up 9.0% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is down $3.12 (-0.7%) to $425.92 on heavy volume. Thus far, 507,312 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 434,600 shares. The stock has ranged in price between $417.80-$428.40 after having opened the day at $427.56 as compared to the previous trading day's close of $429.04.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $17.3 billion and is part of the health care sector. Shares are down 12.3% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is down $0.40 (-0.6%) to $64.90 on light volume. Thus far, 1.3 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.7 million shares. The stock has ranged in price between $64.75-$65.36 after having opened the day at $65.20 as compared to the previous trading day's close of $65.30.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $52.9 billion and is part of the health care sector. Shares are up 19.9% year to date as of the close of trading on Friday. Currently there are 14 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Express Scripts Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices